Page 23 - Preclinical Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Living History: Our Role in Global Scientific Collaboration for SARS-CoV-2, Upcoming Webinar Hosted by Xtalks Share Article In this free webinar, the featured speakers will reflect on the past year of the COVID-19 pandemic and discuss their contribution to vaccine development. They will also discuss what is needed to prepare or respond faster to other infectious agents, and how to assess the impact of SARS-CoV-2 variants of concern (VOC) on vaccine/drug efficacy. The webinar will also highlight the difference between a wild-type neutralization assay and a surrogate pseudoparticle neutralizati...

Created by an industry veteran with more than 20 years’ experience, Protodigm aims to offer innovation and expertise to pharmaceutical industry clients.

Emmaus Life Sciences Reports Annual Financial Results for 2020 and Provides Updated Business Review -- Net Revenues Increased Despite COVID-19 Pandemic-Related Challenges -- -- Improved Overall Operating Results and Net Income vs. Net Loss in 2019 -- News provided by Share this article TORRANCE, Calif., May 4, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, announced today its financial results for the year ended December 31, 2020 as reported in its Annual Report on Form 10-K filed ...

REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapy's 24th Annual Meeting News provided by Share this article Share this article ROCKVILLE, Md., April 27, 2021 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that four oral and nine poster presentations will be presented at the American Society of Gene and Cell Therapy's 24 th Annual Meeting taking place from May 11 to 14, 2021, in virtual format. Presentations and posters will be available at https://www.asgct.org/. Oral presentations include: Abstract Title: Effects of Sexual Dimorphism and Gen...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ImCheck Therapeutics Appoints Dr. Loui Madakamutil as CSO ImCheck Therapeutics SASApril 15, 2021 GMT ImCheck Therapeutics Appoints Dr. Loui Madakamutil, Noted Expert in Immunology and Autoimmune Diseases, as Chief Scientific Officer Marseille, France, April 15, 2021 – ImCheck Therapeutics today announced the appointment of Loui Madakamutil, PhD, as Chief Scientific Officer (CSO). Dr. Madakamutil brings over 20 years of experience in developing transformative therapies that harness the immune syste...